Johnson & Johnson CARVYKTI — Percent Change (as a percent) increased by 885.7% to 62.1% in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase reflects accelerating adoption or market expansion, whereas a decrease suggests a deceleration in growth or potential loss of market share.
This metric measures the period-over-period percentage growth or decline in net sales for a specific therapeutic product...
Comparable to year-over-year or sequential product growth rates reported by pharmaceutical companies for their key growth drivers.
jnj_segment_carvykti_percent_change_as_a_percent| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | 99.8% | 59.8% | 87.7% | 8.4% | 83.5% | 6.3% | 62.1% |
| QoQ Change | — | -40.1% | +46.7% | -90.4% | +894.0% | -92.5% | +885.7% |
| YoY Change | — | — | — | — | -4.8% | -25.0% | — |